miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB

Resistance to tamoxifen is a major clinical challenge. Research in recent years has identified epigenetic changes as mediated by dysregulated miRNAs that can possibly play a role in resistance to tamoxifen in breast cancer patients expressing estrogen receptor (ER). We report here elevated levels of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yu, Zhang, Wenzhi, Liu, Chengwen, Li, Guanghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906507/
https://www.ncbi.nlm.nih.gov/pubmed/31827114
http://dx.doi.org/10.1038/s41598-019-54289-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906507/
https://www.ncbi.nlm.nih.gov/pubmed/31827114
http://dx.doi.org/10.1038/s41598-019-54289-6

Ejemplares similares